JD.com, Inc. operates as a supply chain-based technology and service provider in the People's Republic of China. The company offers computers, communication, and consumer electronics products, as well as home appliances; and general merchandise products comprising food, beverage and fresh produce, baby and maternity products, furniture and household goods, cosmetics and other personal care items, pharmaceutical and healthcare products, industrial products, books, automobile accessories, apparel and footwear, bags, and jewelry. It also provides online marketplace services for third-party merchants; marketing services; and omni-channel solutions to customers and offline retailers, as well as online healthcare services. In addition, the company develops, owns, and manages its logistics facilities and other real estate properties to support third parties; offers asset management services and integrated service platform; leasing of storage facilities and related management services; and engages in online retail business. Further, it provides integrated data, technology, business, and user management industry solutions to support the digitization of enterprises and institutions; and technology-driven supply chain solutions and logistics services. The company was formerly known as 360buy Jingdong Inc. and changed its name to JD.com, Inc. in January 2014. JD.com, Inc. was incorporated in 2006 and is headquartered in Beijing, the People's Republic of China.

JD.com Inc.

Endeavour Silver ( ($TSE:EDR) ) just unveiled an update. Endeavour Silver Corp. is a Vancouver-based precious metals producer focused on undergroun...

Endeavour Silver Posts Surging Q2 2026 Profits on Higher Output and Prices

Precise Biometrics AB ( ($SE:PREC) ) just unveiled an announcement. Precise Biometrics CEO Joakim Nydemark has been interviewed in Dagens Industri’...

Precise Biometrics CEO Highlights Merger Strategy and Rights Issue in Dagens Industri Podcast

Rightmove ( ($GB:RMV) ) has shared an announcement. Rightmove plc has continued its long-running capital return strategy by repurchasing 102,000 or...

Rightmove Continues Long-Running Share Buy-Back as It Cancels New Batch of Shares

Valbiotis SA ( ($FR:ALVAL) ) has provided an announcement. Valbiotis is positioning itself as a specialist in preventive cardiometabolic solutions,...

Valbiotis Backs France’s Cardiovascular Prevention Push

Rightmove ( ($GB:RMV) ) has shared an announcement. Rightmove plc has continued its long-running share buy-back strategy, repurchasing 150,000 ordi...

Rightmove Extends Long-Running Share Buy-Back Programme

J D Wetherspoon ( ($GB:JDW) ) has issued an announcement. J D Wetherspoon has issued a detailed rebuttal to a Financial Times article suggesting th...

Wetherspoon Rebuts FT Claims on Gambling Machine Profits

The latest announcement is out from Rightmove ( ($GB:RMV) ). Rightmove plc has continued to execute its long-running share buy-back strategy, purch...

Rightmove Extends Long-Running Share Buy-Back with Fresh 150,000-Share Purchase

Morgan Stanley analyst Michael Ulz maintained a Buy rating on Ionis Pharmaceuticals today and set a price target of $110.00. According to TipRanks,...

Morgan Stanley Sticks to Its Buy Rating for Ionis Pharmaceuticals (IONS)

Berenberg Bank analyst reiterated a Buy rating on Judges Scientific today and set a price target of p5,600.00. Currently, the analyst consensus on ...

Judges Scientific (JDG) Receives a Buy from Berenberg Bank

In a report released yesterday, from Shore Capital reiterated a Hold rating on J D Wetherspoon. The company’s shares closed yesterday at p722.50. T...

Shore Capital Sticks to Their Hold Rating for J D Wetherspoon (JDW)

Barclays analyst Richard Taylor maintained a Sell rating on J D Wetherspoon today and set a price target of £5.40. According to TipRanks, Taylor is...

J D Wetherspoon (JDW) Receives a Sell from Barclays

The latest announcement is out from Bluejay Diagnostics ( ($BJDX) ). On July 21, 2026, Bluejay Diagnostics announced it had completed patient enrol...

Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study

J D Wetherspoon ( ($GB:JDW) ) has shared an update. J D Wetherspoon has issued a corrected pre-close trading update, confirming that like-for-like ...

Wetherspoon warns on profits despite sales growth and estate investment

In a report released yesterday, from CSC Financial maintained a Buy rating on JD.com, Inc. Class A, with a price target of HK$157.49. JD.com, Inc. ...

CSC Financial Sticks to Their Buy Rating for JD.com, Inc. Class A (9618)

An announcement from Precise Biometrics AB ( ($SE:PREC) ) is now available. Precise Biometrics has resolved to carry out a rights issue of up to 13...

Precise Biometrics Launches SEK 110m Rights Issue to Fund Integration After Fingerprint Cards Merger

Rightmove ( ($GB:RMV) ) just unveiled an update. Rightmove plc has continued to execute its long-running share buy-back strategy, repurchasing 150,...

The latest update is out from Judges Scientific ( ($GB:JDG) ). Judges Scientific has disclosed that Chief Financial Officer Brad Ormsby, together w...

Judges Scientific Executives Reinvest Dividends into Company Shares

An update from Precise Biometrics AB ( ($SE:PREC) ) is now available. Precise Biometrics has completed its statutory merger with Fingerprint Cards,...

Precise Biometrics Completes Merger with Fingerprint Cards to Form Global Biometric Player

Just days after warning that “the end is nigh” for the AI trade, famed investor Michael Burry is pointing investors toward a different corner of th...

It’s ‘a Particularly Good Time’ to Buy These Beaten-Down Chinese Tech Stocks, Says Michael Burry

GF Securities analyst maintained a Buy rating on JD.com, Inc. Class A yesterday and set a price target of HK$149.21. Currently, the analyst consens...

GF Securities Reaffirms Their Buy Rating on JD.com, Inc. Class A (9618)

Guotai Haitong analyst maintained a Buy rating on JD.com, Inc. Class A on July 15 and set a price target of HK$136.50. The company’s shares closed ...

Guotai Haitong Remains a Buy on JD.com, Inc. Class A (9618)

In a report released on July 15, from CLSA maintained a Buy rating on JD.com, Inc. Class A, with a price target of HK$150.15. The company’s shares ...

JD.com, Inc. Class A (9618) Receives a Buy from CLSA

An update from Rightmove ( ($GB:RMV) ) is now available. Rightmove plc has continued its longstanding share buy-back strategy, repurchasing 150,000...

Rightmove Continues Long-Running Share Buy-Back With New 150,000-Share Purchase

The latest announcement is out from J D Wetherspoon ( ($GB:JDW) ). J D Wetherspoon has disclosed a series of small share purchases by senior execut...

Wetherspoon directors add shares under employee partnership plan

In a report released yesterday, from CSC Financial maintained a Buy rating on JD.com, Inc. Class A, with a price target of HK$157.49. The word on T...

CSC Financial Sticks to Its Buy Rating for JD.com, Inc. Class A (9618)

CICC analyst maintained a Buy rating on JD.com, Inc. Class A on July 14 and set a price target of HK$140.40. In a report released yesterday, DBS al...

JD.com, Inc. Class A (9618) Receives a Buy from CICC

In a report released on July 14, from CMB International Securities maintained a Buy rating on JD.com, Inc. Class A, with a price target of HK$185.2...

CMB International Securities Remains a Buy on JD.com, Inc. Class A (9618)

In a report released yesterday, from UOB Kay Hian maintained a Buy rating on JD.com, Inc. Class A, with a price target of HK$156.00. Currently, the...

UOB Kay Hian Sticks to Their Buy Rating for JD.com, Inc. Class A (9618)

In a report released on July 13, from Daiwa maintained a Hold rating on JD.com, Inc. Class A, with a price target of HK$108.00. The company’s share...

Daiwa Sticks to Their Hold Rating for JD.com, Inc. Class A (9618)

In a report released today, Ben Wong from DBS maintained a Buy rating on JD.com, Inc. Class A, with a price target of HK$141.00. According to TipRa...

DBS Remains a Buy on JD.com, Inc. Class A (9618)

Rightmove ( ($GB:RMV) ) has issued an update. Rightmove plc has corrected a previous notice and confirmed it will publish its half-year results for...

Rightmove Confirms Correct Date for 2026 Half-Year Results

In a report released today, Jiong Shao from Barclays maintained a Buy rating on JD, with a price target of $41.00. According to TipRanks, Shao is a...

JD (JD) Gets a Buy from Barclays

In a report released yesterday, from China Merchants Securities maintained a Buy rating on JD.com, Inc. Class A, with a price target of HK$144.00. ...

China Merchants Securities Remains a Buy on JD.com, Inc. Class A (9618)

Huatai Securities analyst maintained a Buy rating on JD.com, Inc. Class A yesterday and set a price target of HK$152.09. In a report released on Ju...

Huatai Securities Sticks to Its Buy Rating for JD.com, Inc. Class A (9618)

Morgan Stanley analyst maintained a Sell rating on JD.com, Inc. Class A on July 13 and set a price target of HK$105.30. The company’s shares closed...

Morgan Stanley Keeps Their Sell Rating on JD.com, Inc. Class A (9618)

Nomura analyst maintained a Buy rating on JD.com, Inc. Class A on July 13 and set a price target of HK$159.90. The company’s shares closed yesterda...

Nomura Remains a Buy on JD.com, Inc. Class A (9618)

UBS analyst maintained a Buy rating on JD.com, Inc. Class A on July 13 and set a price target of HK$187.20. The company’s shares closed yesterday a...

JD.com, Inc. Class A (9618) Gets a Buy from UBS

Nvidia ($NVDA) and AMD ($AMD) shares moved higher on Tuesday after a Reuters report said three Chinese companies, including a unit of telecom equip...

Nvidia and AMD Stocks Rise on a Positive Shift in China’s AI Chips Scenario

The latest update is out from Rightmove ( ($GB:RMV) ). Rightmove has continued its long-running capital return strategy by purchasing 150,000 of it...

Rightmove Advances Long-Running Share Buyback Programme

In a report released today, Jessica Fye from J.P. Morgan maintained a Buy rating on Ionis Pharmaceuticals, with a price target of $72.00. According...

J.P. Morgan Keeps Their Buy Rating on Ionis Pharmaceuticals (IONS)

DBS analyst Ben Wong maintained a Buy rating on JD today and set a price target of $36.00. According to TipRanks, Wong is ranked #7449 out of 12329...

DBS Remains a Buy on JD (JD)

An announcement from Judo Capital Holdings Limited ( ($AU:JDO) ) is now available. Judo Capital Holdings Limited has notified the ASX of the cessat...

Judo Capital Updates Market on Lapse of Deferred Rights and Options

There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on JD (JD) and Ferrari (RACE) with bullish senti...

Analysts Offer Insights on Consumer Cyclical Companies: JD (JD) and Ferrari (RACE)

An update from Rightmove ( ($GB:RMV) ) is now available. Rightmove plc has continued executing its long-running share buy-back programme with the p...

Rightmove Cancels 150,000 Shares in Ongoing Buy-Back Programme

UBS analyst John Storey downgraded Judo Capital Holdings Limited to a Hold on July 10 and set a price target of A$1.10. The company’s shares closed...

Judo Capital Holdings Limited (JDO) was downgraded to a Hold Rating at UBS

Wells Fargo analyst maintained a Buy rating on Ionis Pharmaceuticals today and set a price target of $100.00. In addition to Wells Fargo, Ionis Pha...

Wells Fargo Sticks to Its Buy Rating for Ionis Pharmaceuticals (IONS)

In a report released today, Eliana Merle from Barclays maintained a Buy rating on Ionis Pharmaceuticals, with a price target of $90.00. According t...

Barclays Sticks to Their Buy Rating for Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals ( ($IONS) ) just unveiled an update. Ionis Pharmaceuticals and AstraZeneca reported on July 9, 2026, that the large Phase 3 C...

Ionis, AstraZeneca report Phase 3 eplontersen setback

An update from Judges Scientific ( ($GB:JDG) ) is now available. Judges Scientific has disclosed that several senior executives, including the chie...

Judges Scientific Executives Add Shares via Incentive Plan

An announcement from Rightmove ( ($GB:RMV) ) is now available. Rightmove plc has continued to execute its long-running share buy-back programme, re...

Rightmove Continues Share Buy-Back With Latest 150,000-Share Purchase

Iridium Communications ( ($IRDM) ) just unveiled an update. On July 2, 2026, Iridium completed its acquisition of the remaining 61% stake in Aireon...

Iridium Plans Rocket Lab Merger, Boosts Executive Retention

The latest announcement is out from Rightmove ( ($GB:RMV) ). Rightmove plc has continued its long-running share buy-back programme with the purchas...

Precise Biometrics AB ( ($SE:PREC) ) has shared an update. Precise Biometrics has announced the outcome of its issuance of substitute warrants to h...

Precise Biometrics sets terms for substitute warrants in Fingerprint Cards merger

In a report released today, Richard Wiles from Morgan Stanley maintained a Buy rating on Judo Capital Holdings Limited, with a price target of A$1....

Morgan Stanley Sticks to Its Buy Rating for Judo Capital Holdings Limited (JDO)

Rightmove ( ($GB:RMV) ) has shared an announcement. Rightmove plc has continued its longstanding share buy-back strategy, purchasing 150,000 of its...

Rightmove Continues Long-Running Share Buy-Back Programme

An update from J D Wetherspoon ( ($GB:JDW) ) is now available. J D Wetherspoon plc has issued a shareholder circular outlining a proposed Rule 9 wa...

J D Wetherspoon Calls General Meeting on Rule 9 Waiver and Share Buyback Authority

An update from Iovance Biotherapeutics ( ($IOVA) ) is now available. On June 30, 2026, Iovance Biotherapeutics updated its corporate presentation, ...

Iovance updates outlook, highlighting Amtagvi growth and pipeline

Bluejay Diagnostics, Inc. ($BJDX) announced an update on their ongoing clinical study. The Multicenter Symphony IL-6 Monitoring Sepsis ED Pilot Stu...

Bluejay Diagnostics Advances Symphony IL-6 Sepsis Pilot, Keeping Investor Focus on ER Diagnostics

Judo Capital Holdings Limited ( ($AU:JDO) ) has provided an update. Australian Retirement Trust Pty Ltd, acting as trustee for Australian Retiremen...

Australian Retirement Trust exits substantial holder position in Judo Capital

Rightmove ( ($GB:RMV) ) just unveiled an update. Rightmove has continued its long-running capital management strategy by repurchasing 150,000 of it...

Rightmove Cancels New Share Buy-Back Tranche as Long-Running Programme Passes 563m Shares

Tesla ($TSLA) rival UBTECH has unveiled the first mass-produced “emotional companion” humanoid robot with thousands of customers ready to buy it on...

Tesla Needs a Friend as Humanoid Rival UBTECH Unveils ‘Emotional Companion’ Robot

Rightmove ( ($GB:RMV) ) just unveiled an announcement. Rightmove plc has continued its long-running capital return strategy by buying back 154,272 ...

Rightmove Extends Share Buy-Back, Further Shrinks Equity Base

J D Wetherspoon ( ($GB:JDW) ) has issued an update. Wetherspoon has updated the market on its share capital and voting rights following the cancell...

Wetherspoon Updates Market on Share Capital After Share Cancellation

Rightmove ( ($GB:RMV) ) just unveiled an announcement. Rightmove plc has continued its longstanding capital return strategy by repurchasing 160,000...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	JD	$32.20	+1.24%	11.74M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	JD	$32.20	+1.2%	11.74M
3
4
5
6

JD

JD

Get JD.com Inc. Data in Excel

Get JD.com Inc. Data in Excel